Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

Mostrar otras versiones (1)

OBJECTIVE: This study aimed to compare the efficacy and safety of escitalopram, vortioxetine, and desvenlafaxine for acute treatment of major depressive disorder (MDD) with cognitive complaint (CC). METHODS: A total of 129 patients with MDD who also complained of CC were randomized evenly to either...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung-Hoon, Jeon, Sang Won, Shin, Cheolmin, Pae, Chi-Un, Patkar, Ashwin A., Masand, Prakash S., An, Hyonggin, Han, Changsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058271/
https://www.ncbi.nlm.nih.gov/pubmed/35500900
http://dx.doi.org/10.30773/pi.2021.0368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058271/
https://www.ncbi.nlm.nih.gov/pubmed/35500900
http://dx.doi.org/10.30773/pi.2021.0368

Ejemplares similares